- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
EED Antibody / Polycomb Protein EED Polyclonal Antibody targets embryonic ectoderm development protein (EED), a conserved member of the Polycomb group of proteins and an essential component of Polycomb Repressive Complex 2 (PRC2). This chromatin-associated complex regulates gene expression through histone methylation and contributes to the establishment and maintenance of transcriptionally repressive chromatin states. EED plays a central role in coordinating PRC2 activity, allowing cells to maintain appropriate patterns of gene expression during development, differentiation, and cellular identity transitions.
PRC2 contains several core components, including EED, EZH2 or EZH1, SUZ12, and RBBP4 or RBBP7. EZH2 and EZH1 provide the catalytic activity responsible for methylating lysine 27 of histone H3 (H3K27), while EED contributes to the recognition of methylated chromatin and regulation of complex activity. EED contains a seven-bladed WD40 beta-propeller structure that recognizes trimethylated H3K27 and other methylated ligands. Binding of EED to H3K27me3 promotes allosteric activation of PRC2, supporting the propagation of this repressive histone modification across chromatin.
Through its role in PRC2, EED participates in the silencing of genes that must remain inactive in particular cellular contexts. Polycomb-mediated repression is especially important during embryonic development, when cells progressively establish specialized transcriptional programs. EED contributes to the regulation of developmental genes, stem cell differentiation, and the maintenance of lineage-specific gene expression. Disruption of PRC2 function can alter chromatin organization and interfere with normal developmental processes.
EED also has important implications in cancer biology. Abnormal PRC2 activity can contribute to inappropriate repression of genes involved in differentiation and growth regulation. Conversely, loss-of-function alterations affecting PRC2 components occur in certain malignancies, demonstrating that the consequences of altered Polycomb regulation depend on cellular and genetic context. EED has therefore attracted interest as a regulatory component of PRC2 and as a potential target for therapeutic strategies that interfere with complex activity.
Research involving EED Antibody contributes to understanding the relationship between Polycomb protein function, histone methylation, and transcriptional repression. Characterizing EED expression and regulation provides insight into the epigenetic mechanisms that preserve cellular identity and influence developmental and disease-associated gene expression programs.
Explore additional antibodies targeting Polycomb proteins, histone-modifying enzymes, and chromatin-associated regulators in our Epigenetics Antibodies collection.
Optimal dilution of the EED Antibody / Polycomb Protein EED Polyclonal Antibody should be determined by the researcher.
Recombinant human protein (amino acids K77-R441) was used as the immunogen for the Embryonic ectoderm development protein antibody.
After reconstitution, the EED Antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
Embryonic ectoderm development protein antibody, Polycomb protein EED antibody, EED Polycomb protein antibody, Embryonic ectoderm development antibody, PRC2 EED antibody, Polycomb Repressive Complex 2 EED antibody, EED WD40 protein antibody, EED chromatin regulator antibody, EED epigenetic regulator antibody, EED transcriptional repressor antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.